Bioverativ Inc (BIVV) PT Raised to $57 at Stifel Following FY16 Report and FY17 Outlook; 'Trimmed Spend Seems Promising'
Tweet Send to a Friend
Stifel analyst Thomas Shrader raised its price target on Bioverativ Inc (NASDAQ: BIVV) to $57.00 (from $54.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
